about
Hypertension in menopausal women--a special case, for special treatment?Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?Menopause, the metabolic syndrome, and mind-body therapiesLipoprotein(a): an emerging cardiovascular risk factor.Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy.Assessing the economic impact of chronic conditions in postmenopausal women.Study on relation of metabolic syndrome with menopause.Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fractureA comparative study of lipid profile and oestradiol in pre- and post-menopausal women.Sixteen weeks of resistance training can decrease the risk of metabolic syndrome in healthy postmenopausal women.Effect of Half-dose and Standard-dose Conjugated Equine Estrogens Combined with Natural Progesterone or Dydrogesterone on Components of Metabolic Syndrome in Healthy Postmenopausal Women: A Randomized Controlled Trial.Primary prevention of cardiovascular disease with HRT.Endocrinology of menopause.Soy isoflavones and glucose metabolism in menopausal women: A systematic review and meta-analysis of randomized controlled trials.Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.Breast cancer is associated to impaired glucose/insulin homeostasis in premenopausal obese/overweight patients.Atherogenic Lipoprotein Subfractions and Carotid Atherosclerosis in Menopausal Women.A unifying hypothesis of Alzheimer's disease. III. Risk factors.The metabolic syndrome among postmenopausal women in Ecuador.
P2860
Q28191800-BEBF1399-78EB-40E8-BA1A-D1747EA62881Q30234825-EB80DB2F-97F8-4713-9552-DDF9FA714093Q30437308-106DDCD2-A775-400F-92E9-FB75DDD2A59CQ35081894-6199C409-3246-480E-B4C4-AC78025084D7Q35885187-C9D44C75-DE44-46B9-88DC-4B518E0B71ADQ36249907-8D9C9D8E-0D8D-4EEF-B0A5-5E0AC44172DEQ36540795-CC5E5939-A627-4AFD-84F4-6D8348D0DFA1Q37048294-3C04FE45-936F-4F74-BB3A-97CBFC1C9B14Q37197085-37D66836-F67C-49B9-AE90-9A9D97A8FADDQ37198534-C4176A6E-6A7F-43D0-ACEC-3D60EDBE0ECCQ37487595-852ECD41-E197-4459-9F94-CBAC4AF0E1BFQ37968650-3A3F1888-60EB-4D8F-8AE7-B64A5B1FCFECQ38067477-3B681FA7-DD45-467C-B049-BD8DBFCFD55AQ38785296-F17FFB2E-03FF-4E35-8613-E20E5933D429Q43763137-9313364B-25DA-4DB6-B675-758D9DD02EF7Q47169220-59311398-4F39-47EE-80DB-7021E6D170FAQ48229572-C9EACF77-2D96-4DDA-8985-FC028A346B4BQ48458709-B7DE3603-1A47-4A79-A74A-CD15C5E30DECQ51488582-BC05EC17-4CF3-4AEA-A5EC-4CA136B24924
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Is there a menopausal metabolic syndrome?
@en
type
label
Is there a menopausal metabolic syndrome?
@en
prefLabel
Is there a menopausal metabolic syndrome?
@en
P2093
P2860
P1476
Is there a menopausal metabolic syndrome?
@en
P2093
Godsland IF
Spencer CP
Stevenson JC
P2860
P304
P356
10.3109/09513599709152559
P577
1997-10-01T00:00:00Z